New balloon treatment tackles stubborn artery blockages
NCT ID NCT05731700
First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 27 times
Summary
This study tested a special balloon coated with the drug everolimus to treat in-stent restenosis, where a previously placed stent becomes blocked again. Fifty-one adults with this condition received the balloon treatment to open the artery and prevent future narrowing. The goal was to see if the balloon is safe and effective at keeping arteries open over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IN-STENT RESTENOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinique Pasteur
Toulouse, 31300, France
-
Georgian Israeli Research Medical Centre Helsicore
Tbilisi, Georgia
-
Groupe Hospitalier Mutualiste de Grenoble
Grenoble, 38000, France
-
Hospital Clínic de Barcelona
Barcelona, 08036, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Hospital Universitario de La Princesa
Madrid, 28006, Spain
-
L'Hôpital Privé du Confluent
Nantes, 44000, France
-
Tbilisi Heart and Vascular Clinic
Tbilisi, 0159, Georgia
-
Vilniaus universiteto ligoninė Santaros klinikos
Vilnius, 08410, Lithuania
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.